Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3120021000168112 | Aclasta (zoledronic acid 5 mg / 100 mL) injection, 6 x 100 mL vials (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3120031000168110 | Aclasta 5 mg/100 mL injection, 6 x 100 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Aclasta 5 mg/100 mL injection, 6 x 100 mL vials | Is a | trade product pack | true | Inferred relationship | Some | ||
| Aclasta 5 mg/100 mL injection, 6 x 100 mL vials | Is a | zoledronic acid 5 mg/100 mL injection, 6 x 100 mL vials | true | Inferred relationship | Some | ||
| Aclasta 5 mg/100 mL injection, 6 x 100 mL vials | has TPUU | Aclasta 5 mg/100 mL injection, 100 mL vial | true | Inferred relationship | Some | 1 | |
| Aclasta 5 mg/100 mL injection, 6 x 100 mL vials | has TP | Aclasta | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Aclasta 5 mg/100 mL injection, 6 x 100 mL vials | Is a | True | Aclasta 5 mg/100 mL injection, 6 x 100 mL vials | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR